You are using an older browser version. Please use a supported version for the best MSN experience.

Covid drugs haven't been a major contributor to our revenue, says Indian pharmaceutical firm

Vinita Gupta of Lupin discusses what's in the company's pipeline.
image beaconimage beaconimage beacon